Clinical trial
Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in…
NCT00286013 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00286013 |
|---|---|
| Title | Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma |
| Official title | Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma |
| Lead sponsor | University Hospital, Ghent, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Locally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma |
| Intervention type | Drug |
| Interventions | Association of gemcitabine, oxaliplatin and radiotherapy |
| Enrollment | 24 |
| Start date | May 1, 2004 |
| Primary completion | May 31, 2006 |
| Completion | Jul 22, 2008 |
| First posted | Feb 2, 2006 |
| Last update posted | Dec 9, 2022 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: